突破压力性尿失禁护理的障碍：TAS-303成为药理学创新的变革者。 - Suppr

Breaking barriers in stress urinary incontinence care: TAS-303 as a game-changer in pharmacological innovation.

作者信息

May Matthias, Schleder Martina, Kravchuk Anton, Wolff Ingmar, Siepmann Stephan, Braun Kay-Patrick, Gilfrich Christian

机构信息

Department of Urology, St. Elisabeth Hospital Straubing, Brothers of Mercy Hospital, Straubing, Germany.

Interdisciplinary Uro-Oncology Center, St. Elisabeth Hospital Straubing, Brothers of Mercy Hospital, Straubing, Germany.

出版信息

Transl Androl Urol. 2025 Feb 28;14(2):196-201. doi: 10.21037/tau-2024-691. Epub 2025 Feb 25.

DOI:10.21037/tau-2024-691

PMID:40114827

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11921414/

Abstract

摘要

相似文献

Breaking barriers in stress urinary incontinence care: TAS-303 as a game-changer in pharmacological innovation.

Transl Androl Urol. 2025 Feb 28;14(2):196-201. doi: 10.21037/tau-2024-691. Epub 2025 Feb 25.

TAS-303 effects on urethral sphincter function in women with stress urinary incontinence: phase I study.

Int Urogynecol J. 2021 Mar;32(3):673-680. doi: 10.1007/s00192-020-04470-7. Epub 2020 Oct 10.

TAS-303, a Novel Selective Norepinephrine Reuptake Inhibitor that Increases Urethral Pressure in Rats, Indicating Its Potential as a Therapeutic Agent for Stress Urinary Incontinence.

J Pharmacol Exp Ther. 2018 Aug;366(2):322-331. doi: 10.1124/jpet.118.248039. Epub 2018 Jun 6.

Midterm postoperative results of mid-urethral slings. Role of ultrasound in explaining surgical failures.

Neurourol Urodyn. 2022 Nov;41(8):1834-1843. doi: 10.1002/nau.25032. Epub 2022 Sep 4.

The new etiology and surgical therapy of stress urinary incontinence in women.

Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:26-34. doi: 10.1016/j.ejogrb.2019.11.023. Epub 2019 Nov 28.

Urethral bulking agents and pelvic floor muscle training for the treatment of stress urinary incontinence in female patients with multiple sclerosis.

Bladder (San Franc). 2025 Jan 17;11(4):e21200028. doi: 10.14440/bladder.2024.0049. eCollection 2024.

Impact of the availability of midurethral slings on treatment strategies for stress urinary incontinence: a cost-effectiveness analysis.

BJOG. 2022 Feb;129(3):500-508. doi: 10.1111/1471-0528.16850. Epub 2021 Aug 17.

Association of Baseline Pelvic Floor Muscle Activities With Sexual and Urinary Functions In Female Stress Urinary Incontinence.

J Sex Med. 2021 Oct;18(10):1698-1704. doi: 10.1016/j.jsxm.2021.07.013. Epub 2021 Aug 24.

Vaginal Pessaries for Pelvic Organ Prolapse or Stress Urinary Incontinence: A Health Technology Assessment.

Ont Health Technol Assess Ser. 2021 May 6;21(3):1-155. eCollection 2021.

Pelvic floor parameters predict postpartum stress urinary incontinence: a prospective MRI study.

Insights Imaging. 2023 Sep 27;14(1):160. doi: 10.1186/s13244-023-01488-5.

本文引用的文献

Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.

J Urol. 2024 Aug;212(2):267-279. doi: 10.1097/JU.0000000000004024. Epub 2024 Jul 9.

Pharmacotherapy in Stress Urinary Incontinence; A Literature Review.

Curr Urol Rep. 2024 Jul;25(7):141-148. doi: 10.1007/s11934-024-01205-9. Epub 2024 May 10.

Urinary Incontinence and Pelvic Organ Prolapse in Women.

Dtsch Arztebl Int. 2023 Feb 3;120(5):71-80. doi: 10.3238/arztebl.m2022.0406.

[Genitourinary menopause syndrome. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].

Gynecol Obstet Fertil Senol. 2021 May;49(5):394-413. doi: 10.1016/j.gofs.2021.03.025. Epub 2021 Mar 20.

Efficacy and safety of the noradrenaline reuptake inhibitor, TAS-303, in women with stress urinary incontinence: Results of a double-blind, randomized, placebo-controlled, early phase II trial.

Int J Urol. 2021 Jan;28(1):82-90. doi: 10.1111/iju.14411. Epub 2020 Nov 3.

TAS-303 effects on urethral sphincter function in women with stress urinary incontinence: phase I study.

Int Urogynecol J. 2021 Mar;32(3):673-680. doi: 10.1007/s00192-020-04470-7. Epub 2020 Oct 10.

Therapeutic potential of muscle growth promoters in a stress urinary incontinence model.

Am J Physiol Renal Physiol. 2020 Sep 1;319(3):F436-F446. doi: 10.1152/ajprenal.00122.2020. Epub 2020 Jul 20.

Use of Duloxetine for Postprostatectomy Stress Urinary Incontinence: A Systematic Review.

Eur Urol Focus. 2021 May;7(3):618-628. doi: 10.1016/j.euf.2020.06.007. Epub 2020 Jun 27.

New concepts in regenerative medicine approaches to the treatment of female stress urinary incontinence.

Curr Opin Urol. 2019 Jul;29(4):380-384. doi: 10.1097/MOU.0000000000000617.

TAS-303, a Novel Selective Norepinephrine Reuptake Inhibitor that Increases Urethral Pressure in Rats, Indicating Its Potential as a Therapeutic Agent for Stress Urinary Incontinence.

J Pharmacol Exp Ther. 2018 Aug;366(2):322-331. doi: 10.1124/jpet.118.248039. Epub 2018 Jun 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Breaking barriers in stress urinary incontinence care: TAS-303 as a game-changer in pharmacological innovation.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献